Author:
Jiang Yang,Liu Zhenquan,Liao Yan,Sun Shuyong,Dai Yajie,Tang Yibo
Abstract
Ischemic stroke (IS) has complex pathological mechanisms, and is extremely difficult to treat. At present, the treatment of IS is mainly based on intravenous thrombolysis and mechanical thrombectomy, but they are limited by a strict time window. In addition, after intravenous thrombolysis or mechanical thrombectomy, damaged neurons often fail to make ideal improvements due to microcirculation disorders. Therefore, finding suitable pathways and targets from the pathological mechanism is crucial for the development of neuroprotective agents against IS. With the hope of making contributions to the development of IS treatments, this review will introduce (1) how related targets are found in pathological mechanisms such as inflammation, excitotoxicity, oxidative stress, and complement system activation; and (2) the current status and challenges in drug development.
Subject
Neurology (clinical),Neurology
Reference196 articles.
1. Mortality of stroke and its subtypes in china: results from a nationwide population-based survey;Chen;Neuroepidemiology.,2017
2. Neuroprotection in acute stroke: targeting excitotoxicity, oxidative and nitrosative stress, and inflammation;Chamorro;Lancet Neurol.,2016
3. Acute ischemic stroke;Powers;N Engl J Med.,2020
4. Transient ischemic attack;Amarenco;Reply N Engl J Med.,2020
5. Tenecteplase versus alteplase for management of acute ischaemic stroke (NOR-TEST): a phase 3, randomised, open-label, blinded endpoint trial;Logallo;Lancet Neurol.,2017
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献